All In MedTech

FDA Clearance Tracker · P240009

Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Oct 11, 2024 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Oct 11, 2024

Approved

Time to decision

196 days

Received Mar 29, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P240009
Device name
Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Applicant location
Raleigh, NC
Received
Mar 29, 2024
Decided
Oct 11, 2024
Decision
Approved
Supplements
9 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NIM

FDA's approval statement

As written in FDA's record.

This Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection is indicated for improving the carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below:• Patients with symptomatic stenosis of the common or internal carotid artery with >=50% as determined by angiography using NASCET methodology, or Patients with asymptomatic stenosis of the common or internal carotid artery with >=80% as determined by angiography using NASCET methodology;• Patients with reference vessel diameters 4.0 – 8.0 mm. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material. The Neuroguard IEP System should always be used in conjunction with an available primary distal embolic protection device as described in the IFU.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NIM. The earliest in FDA's data is P040012, decided Aug 30, 2004.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Contego Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.